Holzmann Martin, Jernberg Tomas, Szummer Karolina, Sartipy Ulrik
Departments of Emergency Medicine, Cardiothoracic Surgery and Anesthesiology, Cardiology, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden.
J Am Heart Assoc. 2014 Mar 4;3(2):e000707. doi: 10.1161/JAHA.113.000707.
Patients with chronic kidney disease have an increased risk of death after myocardial infarction, coronary artery bypass graft surgery (CABG), and percutaneous coronary intervention. We sought to describe the association between chronic kidney disease and long-term cardiovascular outcomes and death in patients who underwent CABG for acute coronary syndromes.
All patients (N=12 956) from the Swedish Web System for Enhancement and Development of Evidence-Based Care in Heart Disease Evaluated According to Recommended Therapies (SWEDEHEART) registry who underwent CABG for acute coronary syndromes in Sweden between 2000 and 2008 with complete information on preoperative serum creatinine values were included. Estimated glomerular filtration rates (eGFRs) were obtained, and hazard ratios with 95% CIs were calculated for the composite end point of myocardial infarction, heart failure, stroke, or death in relation to eGFR. During a mean follow-up of 3.5 years, there were in total 2844 (22%) cardiovascular events and 1340 (10%) deaths. In patients with eGFR >60 mL/min per 1.73 m(2), 45 to 60 mL/min per 1.73 m(2), and 15 to 45 mL/min per 1.73 m(2), there were 2896 (28%), 882 (43%), and 407 (61%) cardiovascular events or deaths, respectively. Hazard ratios with 95% CIs for death or any cardiovascular event in patients with eGFR 45 to 60 mL/min per 1.73 m(2), and 15 to 45 mL/min per 1.73 m(2) were 1.07 (0.98 to 1.15) and 1.36 (1.22 to 1.53) respectively, after multivariable adjustment. The corresponding figures for any cardiovascular event were 1.08 (0.98 to 1.19), and 1.24 (1.08 to 1.43).
Severe, but not moderate, renal dysfunction was independently associated with an increased risk of long-term cardiovascular events and death in patients undergoing CABG for acute coronary syndromes.
慢性肾脏病患者在心肌梗死、冠状动脉搭桥手术(CABG)和经皮冠状动脉介入治疗后死亡风险增加。我们试图描述慢性肾脏病与因急性冠状动脉综合征接受CABG治疗的患者长期心血管结局和死亡之间的关联。
纳入瑞典心脏病循证护理强化与发展网络系统(SWEDEHEART)注册中心2000年至2008年间在瑞典因急性冠状动脉综合征接受CABG且术前血清肌酐值信息完整的所有患者(N = 12956)。获取估计肾小球滤过率(eGFR),并计算与eGFR相关的心肌梗死、心力衰竭、中风或死亡复合终点的风险比及95%可信区间。在平均3.5年的随访期间,共有2844例(22%)发生心血管事件,1340例(10%)死亡。eGFR>60 ml/min per 1.73 m²、45至60 ml/min per 1.73 m²和15至45 ml/min per 1.73 m²的患者中,分别有2896例(28%)、882例(43%)和407例(61%)发生心血管事件或死亡。多变量调整后,eGFR为45至60 ml/min per 1.73 m²和15至45 ml/min per 1.73 m²的患者死亡或任何心血管事件的风险比及95%可信区间分别为1.07(0.98至1.15)和1.36(1.22至1.53)。任何心血管事件的相应数字分别为1.08(0.98至1.19)和1.24(1.08至1.43)。
严重而非中度肾功能不全与因急性冠状动脉综合征接受CABG治疗的患者长期心血管事件和死亡风险增加独立相关。